Chapurlat R - Search Results

1

Bone histomorphometry of transiliac paired bone biopsies after 6 or 12 months of treatment with oral strontium ranelate in 387 osteoporotic women: randomized comparison to alendronate.

Chavassieux P, Meunier PJ, Roux JP, Portero-Muzy N, Pierre M, Chapurlat R. Chavassieux P, et al. Among authors: chapurlat r. J Bone Miner Res. 2014 Mar;29(3):618-28. doi: 10.1002/jbmr.2074. J Bone Miner Res. 2014. PMID: 23959630 Free article. Clinical Trial.

2

Dual energy X-ray absorptiometry in patients with lower limb reflex sympathetic dystrophy syndrome.

Chapurlat RD, Duboeuf FP, Liens D, Meunier PJ. Chapurlat RD, et al. J Rheumatol. 1996 Sep;23(9):1557-9. J Rheumatol. 1996. PMID: 8877925

3

Long-term effects of intravenous pamidronate in fibrous dysplasia of bone.

Chapurlat RD, Delmas PD, Liens D, Meunier PJ. Chapurlat RD, et al. J Bone Miner Res. 1997 Oct;12(10):1746-52. doi: 10.1359/jbmr.1997.12.10.1746. J Bone Miner Res. 1997. PMID: 9333137 Free article. Clinical Trial.

4

The nonsurgical treatment of fibrous dysplasia.

Chapurlat R, Meunier PJ. Chapurlat R, et al. Rev Rhum Engl Ed. 1999 Jan;66(1):1-3. Rev Rhum Engl Ed. 1999. PMID: 10036690 No abstract available.

5

[Bisphosphonates and bone remodeling: effectiveness in Paget's disease, fibrous dysplasia and osteoporosis].

Chapurlat R, Meunier PJ. Chapurlat R, et al. Rev Chir Orthop Reparatrice Appar Mot. 1998 Nov;84(8):743-51. Rev Chir Orthop Reparatrice Appar Mot. 1998. PMID: 10192126 Review. French.

6

Serum type I collagen breakdown product (serum CTX) predicts hip fracture risk in elderly women: the EPIDOS study.

Chapurlat RD, Garnero P, Bréart G, Meunier PJ, Delmas PD. Chapurlat RD, et al. Bone. 2000 Aug;27(2):283-6. doi: 10.1016/s8756-3282(00)00325-2. Bone. 2000. PMID: 10913923 Clinical Trial.

7

Fibrous dysplasia of bone.

Chapurlat RD, Meunier PJ. Chapurlat RD, et al. Baillieres Best Pract Res Clin Rheumatol. 2000 Jun;14(2):385-98. doi: 10.1053/berh.1999.0071. Baillieres Best Pract Res Clin Rheumatol. 2000. PMID: 10925751 Review.

8

Serum estradiol and sex hormone-binding globulin and the risk of hip fracture in elderly women: the EPIDOS study.

Chapurlat RD, Garnero P, Bréart G, Meunier PJ, Delmas PD. Chapurlat RD, et al. J Bone Miner Res. 2000 Sep;15(9):1835-41. doi: 10.1359/jbmr.2000.15.9.1835. J Bone Miner Res. 2000. PMID: 10977003 Free article.

9

Treatment of fibrous dysplasia of bone with intravenous pamidronate: long-term effectiveness and evaluation of predictors of response to treatment.

Chapurlat RD, Hugueny P, Delmas PD, Meunier PJ. Chapurlat RD, et al. Bone. 2004 Jul;35(1):235-42. doi: 10.1016/j.bone.2004.03.004. Bone. 2004. PMID: 15207763

10

Risk of fracture among women who lose bone density during treatment with alendronate. The Fracture Intervention Trial.

Chapurlat RD, Palermo L, Ramsay P, Cummings SR. Chapurlat RD, et al. Osteoporos Int. 2005 Jul;16(7):842-8. doi: 10.1007/s00198-004-1770-7. Epub 2004 Dec 3. Osteoporos Int. 2005. PMID: 15580479 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

412 results

Search Page

Filters